`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`
`
`
`
`
`
`
`Case No. IPR2020-01318
`U.S. Patent No. 9,220,631
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`Petitioner Regeneron Pharmaceuticals, Inc. hereby submits its updated
`
`mandatory notices pursuant to 37 C.F.R. § 42.8(a)(3).
`
`
`
`
`
`
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) - Unchanged
`
`The real party-in-interest is Regeneron Pharmaceuticals, Inc.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2)) - Updated
`
`On June 19, 2020, Novartis Pharma AG, Novartis Pharmaceuticals
`
`Corporation, and Novartis Technology LLC filed a complaint at the U.S.
`
`International Trade Commission alleging that Petitioner infringes claims 1-6 and
`
`11-26 of U.S. Patent No. 9,220,631 (the ’631 Patent), and that a domestic industry
`
`exists with respect to claims 1-10 and 14-26 of the ’631 Patent. On the same day,
`
`Novartis Pharma AG, Novartis Pharmaceuticals Corporation, and Novartis
`
`Technology LLC filed a complaint in the United States District Court for the
`
`Northern District of New York alleging that Petitioner infringes at least claim 1 of
`
`the ’631 Patent (N.D.N.Y. 1:20-cv-00690-TJM-CFH).
`
`On July 16, 2020, Petitioner filed the following petitions for inter partes
`
`review against the ’631 Patent: IPR2020-01317 and IPR2020-01318.
`
`
`
`On July 17, 2020, Petitioner filed a complaint in the United States District
`
`Court for the Southern District of New York against Novartis Pharma AG,
`
`Novartis Technology LLC, Novartis Pharmaceuticals Corporation (collectively
`
`“Novartis”), and Vetter Pharma International GmbH (“Vetter”) (S.D.N.Y. 1:20-cv-
`
`
`
`
`2
`
`
`
`00502-AJN). The complaint seeks judgment that (i) Novartis’s and Vetter’s
`
`conduct violates Section 1 of the Sherman Act, 15 U.S.C. § 1; (ii) Novartis’s
`
`conduct violates Section 2 of the Sherman Act, 15 U.S.C. § 2; and (iii) the ’631
`
`Patent be declared unenforceable. The complaint also seeks damages and
`
`injunctive relief restraining and enjoining Novartis and Vetter from continuing the
`
`unlawful conduct in violation of the Sherman Act.
`
`C. Lead and Back-Up Counsel and Service Information (37 C.F.R. §
`42.8(b)(3)-(4)) - Unchanged
`
`Petitioner identifies the following lead and back-up counsel and service
`
`
`
`information:
`
`Lead Counsel
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`
`
`Back-Up Counsel
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTO Reg. No. 68,511
`
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`
`
`
`
`3
`
`
`
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`andrew.gesior@weil.com
`USPTO Reg. No. 76,588
`
`Brian E. Ferguson
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`brian.ferguson@weil.com
`USPTO Reg. No. 36,801
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTO Reg. No. 73,851
`
`
`Please address all correspondence to lead and backup counsel. Petitioner
`
`consents to service by electronic mail at the following address:
`
`Regeneron.IPR.Service@weil.com.
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`Date: July 28, 2020
`
`
`
` Respectfully submitted,
`
`/Elizabeth Stotland Weiswasser /
`Elizabeth Stotland Weiswasser
`Reg. No. 55,721
`Lead Counsel for Petitioner
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`elizabeth.weiswasser@weil.com
`
`
`
`
`5
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on July 28,
`
`
`
`
`2020, a copy of PETITIONER’S UPDATED MANDATORY NOTICES
`
`PURSUANT TO 37 C.F.R. § 42.8 was sent via FedEx next business day delivery
`
`to the following:
`
`
`Michael Mazza
`Daniel Woods
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`One Health Plaza 433
`East Hanover, NJ 07936-1080
`
`
`/Timothy J. Andersen/
`Timothy J. Andersen
`Case Manager
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`202-682-7000
`timothy.andersen@weil.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
